Skip to main content

Antonio Álvarez Fernandez

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca
Antonio Álvarez Fernandez

Projects

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: Ricardo Pujol Borrell
Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Marta Miarons Font , Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino , Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Primary ciliary dyskinesia in adult bronchiectasis. Diagnostic strategy based on next generation sequencing gene panel analysis.

IP: Antonio Moreno Galdó
Collaborators: Antonio Álvarez Fernandez, David Clofent Alarcón, Sandra Rovira Amigo, Alba Torrent Vernetta, Nuria Camats Tarruella
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI20/01419
Duration: 01/01/2021 - 31/12/2023

EVALUAR LA UTILIDAD DE UNA NUEVA TÉCNICA EN EL DIAGNÓSTICO DE LAS INFECCIONES POR MICOBACTERIAS NO TUBERCULOSAS.

IP: Antonio Álvarez Fernandez
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)150/2019
Duration: -

European Cystic Fibrosis Registry (Registro Europeo de Fibrosis Quística)

IP: Antonio Álvarez Fernandez
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)251/2016
Duration: -

Related news

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.

The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.

Related professionals

Alejandro Gines  Puertas

Alejandro Gines Puertas

Read more
Miriam de Nadal Clanchet

Miriam de Nadal Clanchet

Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Fernando Azpiroz Vidaur

Fernando Azpiroz Vidaur

Head of group
Physiology and Pathophysiology of the Digestive Tract
Read more
Javier Maldonado  Pijoan

Javier Maldonado Pijoan

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.